These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31903146)

  • 21. Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice.
    Lu H; Zhang C; Song N; Lu C; Tong L; Huang X; Kim YC; Chen J; Xu W
    Cell Physiol Biochem; 2017; 43(1):158-171. PubMed ID: 28848093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells.
    Li J; Ma W; Cheng X; Zhang X; Xie Y; Ji Z; Wu S
    Arch Biochem Biophys; 2020 Jul; 687():108363. PubMed ID: 32335049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The APC/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer.
    Yan D; He Q; Pei L; Yang M; Huang L; Kong J; He W; Liu H; Xu S; Qin H; Lin T; Huang J
    Cell Death Dis; 2023 Aug; 14(8):516. PubMed ID: 37573356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
    Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
    Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis.
    Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM
    Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
    Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
    Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression.
    Li Z; Zhao J; Tikhanovich I; Kuravi S; Helzberg J; Dorko K; Roberts B; Kumer S; Weinman SA
    Cell Death Differ; 2016 Apr; 23(4):583-95. PubMed ID: 26470730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand.
    Engström M; Karlsson R; Jönsson JI
    Exp Hematol; 2003 Apr; 31(4):316-23. PubMed ID: 12691919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
    Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
    Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3.
    Zhang H; Zhang Z; Wang S; Zhang S; Bi J
    Biomed Pharmacother; 2018 Jun; 102():626-632. PubMed ID: 29602130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis.
    Tan Y; Zhou Y; Zhang W; Wu Z; Xu Q; Wu Q; Yang J; Lv T; Yan L; Luo H; Shi Y; Yang J
    Cell Oncol (Dordr); 2024 Aug; 47(4):1167-1181. PubMed ID: 38326640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXO3 is essential for CD44 expression in pancreatic cancer cells.
    Kumazoe M; Takai M; Bae J; Hiroi S; Huang Y; Takamatsu K; Won Y; Yamashita M; Hidaka S; Yamashita S; Yamada S; Murata M; Tsukamoto S; Tachibana H
    Oncogene; 2017 May; 36(19):2643-2654. PubMed ID: 27893718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Houttuynia cordata Thunb Promotes Activation of HIF-1A-FOXO3 and MEF2A Pathways to Induce Apoptosis in Human HepG2 Hepatocellular Carcinoma Cells.
    Kim JM; Hwang IH; Jang IS; Kim M; Bang IS; Park SJ; Chung YJ; Joo JC; Lee MG
    Integr Cancer Ther; 2017 Sep; 16(3):360-372. PubMed ID: 27698266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma.
    Beck D; Zobel J; Barber R; Evans S; Lezina L; Allchin RL; Blades M; Elliott R; Lord CJ; Ashworth A; Porter AC; Wagner SD
    J Biol Chem; 2016 Aug; 291(32):16686-98. PubMed ID: 27268052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
    World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
    Tsuji T; Maeda Y; Kita K; Murakami K; Saya H; Takemura H; Inaki N; Oshima M; Oshima H
    Oncogene; 2021 Apr; 40(17):3072-3086. PubMed ID: 33795838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCL6 promotes glioma and serves as a therapeutic target.
    Xu L; Chen Y; Dutra-Clarke M; Mayakonda A; Hazawa M; Savinoff SE; Doan N; Said JW; Yong WH; Watkins A; Yang H; Ding LW; Jiang YY; Tyner JW; Ching J; Kovalik JP; Madan V; Chan SL; Müschen M; Breunig JJ; Lin DC; Koeffler HP
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3981-3986. PubMed ID: 28356518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.